Gerald Friedland MD

Professor of Medicine (Infectious Diseases) and of Epidemiology (Microbial Diseases)

Departments & Organizations

Yale Medical Group

Office of International Medical Student Education

Office of Student ResearchHIV/AIDSTuberculosisSchool of Public Health: Center for Interdisciplinary Research on AIDSInternal Medicine: Infectious Diseases: AIDS Care Program

Research Interests

HIV care; Injection drug use and HIV; Anti-retroviral agents; Tuberculosis, HIV and TB drug resistant TB; Prevention and treatment in vulnerable populations more...


  • M.D., New York University, 1964

Selected Publications

  • Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH: HIV Co-infection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality. American Journal of Respiratory and Critical Care Medicine. 2010; 181:80-86.
  • McCance-Katz EF, Moody DE, Prathikanti S, Friedland G, Rainey PM, Rifampin, but not Rifabutin, May Produce Opiate Withdrawal in Buprenorphine-Maintained Patients, Drug and Alcohol Dependence, 2011 Nov 1; 118(2-3):326-34. Epub 2011, May 19
  • Shenoi SV, Brooks RP, Barbour R, Altice FL, Zelterman D, Moll AP, Master I, van der Merwe TL, Friedland GH. (2012) Survival from XDR-TB Is Associated with Modifiable Clinical Characteristics in Rural South Africa. PLoS ONE: Research Article, published 06 Mar 2012 10.1371/journal.pone.0031786 PMC3295798.



Latest News


Edit Profile